Carsten Thiel, Ph.D, is President of Europe for EUSA Pharma. Previously he served as Senior Vice President, Europe/Middle East/Africa & Asia Pacific of Alexion where he was responsible for driving the Company’s global commercial operations in these regions, including maximizing the current portfolio as well as guiding the launch of anticipated new products and indications. Thiel had also managed the regional and global functions located at the European headquarters in Switzerland.
Prior to joining Alexion, Carsten served as Vice President, Head of Europe at Amgen from 2011 to 2014. In this role, he led regional operations and was responsible for 10 products in hematology/oncology, nephrology, and bone disorders, and prepared for new product launches in inflammation and cardiology. Mr. Thiel also held various other senior leadership positions at Amgen, including General Manager, Germany, and General Manager, CEE, where he led all markets in Eastern Europe and established the company’s operations in Russia. He also served as Head of the Oncology Franchise in Europe during the time of several blockbuster product launches. Prior to Amgen, Carsten held several sales and marketing leadership roles across Europe at Roche.
Carsten Thiel has a Ph.D. in Molecular Biology and Biochemistry from the Max Planck Institute, Germany, and a Master’s Degree in Biochemistry from the University of Marburg, Germany.